Agradecimentos: This work was partially supported by a Faculty Grant in Global Health to D.G.S. from the Johns Hopkins Center for Global Health; a grant from FAEPEX-UNICAMP (Fundo de Apoio ao Ensino, à Pesquisa e à Extensão-UNICAMP); and a summer research scholarship to Stanley Sowy from the Office...

Agradecimentos: This work was partially supported by a Faculty Grant in Global Health to D.G.S. from the Johns Hopkins Center for Global Health; a grant from FAEPEX-UNICAMP (Fundo de Apoio ao Ensino, à Pesquisa e à Extensão-UNICAMP); and a summer research scholarship to Stanley Sowy from the Office of the Vice President for Research and iotechnology, Western University, Western University of Health Sciences, Pomona, CA. We thank the study patients and Steven Henriksen and Dominique Griffon for providing the research infrastructure and support needed at Western University of Health Sciences and Hannah Mirrashed, John Greenwood, and Marizete Salvadego for technical assistance. E.B.B. has a patent (US patent 7,115,385) for media and methods for cultivation of microorganisms (issued to E.B.B., S. Sontakke, and North Carolina State University.) E.B.B. is the chief scientific officer for Galaxy Diagnostics, a company that provides diagnostic testing for the detection of Bartonella species infection in animals and human patient samples. All other authors have no conflict of interest to declare

Abstract: Human exposure to Bartonella clarridgeiae has been reported only on the basis of antibody detection. We report for the first time an asymptomatic human blood donor infected with B. clarridgeiae, as documented by enrichment blood culture, PCR, and DNA sequencing

Aberto